366 related articles for article (PubMed ID: 9181759)
1. Low-dose intermittent urokinase therapy in chronic symptomatic end-stage arterial disease--clinical relevance for patients with coronary artery disease or peripheral arterial occlusive disease.
Leschke M; Schoebel FC; Strauer BE
Clin Hemorheol Microcirc; 1997; 17(1):59-66. PubMed ID: 9181759
[TBL] [Abstract][Full Text] [Related]
2. Antithrombotic treatment in stable coronary syndromes: long-term intermittent urokinase therapy in end-stage coronary artery disease and refractory angina pectoris.
Schoebel FC; Jax TW; Fischer Y; Strauer BE; Leschke M
Heart; 1997 Jan; 77(1):13-7. PubMed ID: 9038688
[TBL] [Abstract][Full Text] [Related]
3. [Chronic intermittent urokinase therapy: anti-ischemic and hemodynamic effects].
Leschke M; Schoebel FC; Schannwell CM; Peters AJ; Jax TW; Mecklenbeck W; Strauer BE
Z Kardiol; 1997; 86 Suppl 1():85-94. PubMed ID: 9173724
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous treatment of acute multiple limb ischemia.
Mertens H; Van Holsbeeck B; Gryspeerdt S; Gellens P; Baekelandt M; Lefere P
JBR-BTR; 2000 Oct; 83(5):238-42. PubMed ID: 11201538
[TBL] [Abstract][Full Text] [Related]
5. Long-term intermittent urokinase therapy in patients with end-stage coronary artery disease and refractory angina pectoris: a randomized dose-response trial.
Leschke M; Schoebel FC; Mecklenbeck W; Stein D; Jax TW; Müller-Gärtner HW; Strauer BE
J Am Coll Cardiol; 1996 Mar; 27(3):575-84. PubMed ID: 8606267
[TBL] [Abstract][Full Text] [Related]
6. [Fibrinolytic therapy of peripheral arterial occlusive disease].
Sailer S; Pilger E
Wien Med Wochenschr; 1985 Aug; 135(15-16):393-9. PubMed ID: 2932859
[TBL] [Abstract][Full Text] [Related]
7. LYS-plasminogen shortens the duration of local thrombolytic treatment of peripheral arterial occlusions--a randomized controlled trial.
Poredos P; Videcnik V
Wien Klin Wochenschr; 1999 Jan; 111(1):21-5. PubMed ID: 10067266
[TBL] [Abstract][Full Text] [Related]
8. [Chronic intermittent urokinase therapy in inoperable end-stage coronary disease with therapy refractory angina pectoris symptoms].
Leschke M; Mecklenbeck W; Strauer BE
Med Klin (Munich); 1992 Jul; 87(7):385-9. PubMed ID: 1508119
[No Abstract] [Full Text] [Related]
9. Therapeutic application of contrast-enhanced ultrasound and low-dose urokinase for thrombolysis in a porcine model of acute peripheral arterial occlusion.
Ebben HP; Nederhoed JH; Slikkerveer J; Kamp O; Tangelder GW; Musters RJ; Wisselink W; Yeung KK
J Vasc Surg; 2015 Aug; 62(2):477-85. PubMed ID: 24768365
[TBL] [Abstract][Full Text] [Related]
10. API expert consensus document on management of ischemic heart disease.
Association of Physicians of India
J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
[TBL] [Abstract][Full Text] [Related]
11. [Physiopathologic introduction to anesthesia and resuscitation of the vascular patient].
Coriat P
J Mal Vasc; 1998 Feb; 23(1):35-40. PubMed ID: 9551351
[TBL] [Abstract][Full Text] [Related]
12. Adjunctive intracoronary thrombolysis in complicated coronary angioplasty.
Crouch MA; Nappi JM
Ann Pharmacother; 1997 Oct; 31(10):1244-6. PubMed ID: 9337450
[TBL] [Abstract][Full Text] [Related]
13. [Intracoronary thrombolytic therapy in Kawasaki disease and the usefulness of two-dimensional echocardiography in detecting intracoronary thrombi].
Ichinose E; Kato H; Inoue O; Hirata K; Eto Y; Yoshioka F
J Cardiogr; 1985 Mar; 15(1):79-87. PubMed ID: 4067350
[TBL] [Abstract][Full Text] [Related]
14. Chronic-intermittent urokinase therapy in patients with end-stage coronary artery disease and refractory angina pectoris--a pilot study.
Schoebel FC; Leschke M; Jax TW; Stein D; Strauer BE
Clin Cardiol; 1996 Feb; 19(2):115-20. PubMed ID: 8821421
[TBL] [Abstract][Full Text] [Related]
15. Urokinase thrombolysis as initial therapy for acute and non-acute ischemic extremities.
Byrne D; Byrne WD; Kiernan PD; Harshaw W; Bryne J; Fulcher T; Stanton L; Goodman S; Karnaze M
Va Med Q; 1997; 124(1):41-4. PubMed ID: 9009854
[TBL] [Abstract][Full Text] [Related]
16. Intermittent intravenous urokinase for critical limb ischemia in diabetic foot ulceration.
Weck M; Rietzsch H; Lawall H; Pichlmeier U; Bramlage P; Schellong S
Thromb Haemost; 2008 Sep; 100(3):475-82. PubMed ID: 18766265
[TBL] [Abstract][Full Text] [Related]
17. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
Maksimović ZV
Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
[TBL] [Abstract][Full Text] [Related]
18. [Symptomatic therapy refractory myocardial ischemia in coronary heart disease. Chronic intermittent urokinase therapy and invasive therapeutic measures].
Leschke M; Schoebel FC; Strauer BE
Internist (Berl); 1996 Jun; 37(6):597-606. PubMed ID: 8767992
[No Abstract] [Full Text] [Related]
19. [Survey on adherence to hygiene and dietary rules in patients with arterial occlusive disease].
Aligne C; Mosnier M; Mistretta F; Larguier JS
J Mal Vasc; 2000 Jun; 25(3):187-94. PubMed ID: 10906634
[TBL] [Abstract][Full Text] [Related]
20. Peripheral intra-arterial thrombolytic therapy for acute arterial occlusion.
Coen SD; Silverman E
Crit Care Nurse; 1994 Oct; 14(5):23-9. PubMed ID: 7859465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
